Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MNPR will decline by -12.87% over the next 2 Weeks and hit $48.46 by Wednesday, March 11, 2026. In that time frame, MNPR's share price is expected to range between $45.09 and $51.85.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 11, 2026 | 45.09 | 48.46 | 51.85 |
| Mar 10, 2026 | 45.59 | 49.08 | 52.65 |
| Mar 9, 2026 | 47.48 | 50.56 | 53.92 |
| Mar 6, 2026 | 47.19 | 50.45 | 53.79 |
| Mar 5, 2026 | 48.27 | 51.51 | 54.67 |
| Mar 4, 2026 | 48.92 | 52.39 | 55.35 |
| Mar 3, 2026 | 49.83 | 53.00 | 56.31 |
| Mar 2, 2026 | 51.20 | 54.49 | 57.67 |
| Feb 27, 2026 | 51.19 | 54.37 | 57.51 |
| Feb 26, 2026 | 52.42 | 55.43 | 58.65 |
MNPR shares fell -3.47% in Wednesday, February 25, 2026's trading session, dropping from a previous close of $57.62 to move at $55.62. The stock demonstrated notable intraday movement (see MNPR's key stats for a full breakdown), fluctuating between $54.85 and $58.34, a +6.36% trading range. While recent weeks have seen some volatility, MNPR has managed to secure a -6.35% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 228.64K shares changing hands, 122.49K fewer than the previous session. This amounted to $12.72M in total market activity.
Will MNPR Continue Its Downward Trend?
According to analyst ratings and projections for MNPR, Monopar Therapeutics Inc. shares are anticipated to decrease by -7.27%, potentially reaching $51.85 per share by March 11, 2026. Short-term technical indicators currently suggest a neutral sentiment for MNPR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the MNPR stock forecast, now is not the best time to buy MNPR stock because its current trading price is +14.77% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MNPR covering social and institutional perspectives.
MNPR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MNPR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.66% to 40.30%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 45.34%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.19%, maintains a neutral outlook for the long term. Insights into MNPR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Monopar Therapeutics Short-Term Forecasts
MNPR Forecast For Next 5 Days
Our algorithm anticipates Monopar Therapeutics (MNPR) stock could hit $54.72 by Mar 04, 2026. This represents a -1.62% rise from today's price, following a +8.13% change over the past five days.
MNPR Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Monopar Therapeutics Inc. (MNPR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $48.70, which would mean a -12.44% decrease from the current price of $55.62. Projections for this period range from a high of $63.58 to a low of $39.00.
MNPR Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Monopar Therapeutics's price over the next three months point to a rise. MNPR stock is expected to peak at $69.01 on May 07, 2026 after potentially dipping to $49.12 on Mar 19, 2026. On average, MNPR is likely to trade around $59.46 in the coming 90 days.
Monopar Therapeutics Stock Forecast 2025
Based on our predictive models, Monopar Therapeutics (MNPR) is expected to trade between $49.12 and $87.14 throughout 2026. This would result in an average price of $64.75, potentially offering investors a +16.41% return from current levels.
Monopar Therapeutics Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Monopar Therapeutics Inc. (MNPR) is positioned to show a strong performance in February 2026. The price is predicted to move between $51.21 and $63.80, settling at an average of $57.41. This could translate to a +3.22% gain.
March 2026
Based on current market signals, Monopar Therapeutics Inc. is projected to trend march 2026. We forecast a trading range from $49.12 to $65.21, with a likely average price of $57.68. Investors could expect a potential return of +3.70%.
April 2026
Our predictive algorithms indicate Monopar Therapeutics Inc. stock may see a shift in April 2026. The expected range spans $50.82–$68.96, with an average target of $59.94. This represents a positive outlook and a possible gain of +7.77%.
May 2026
Analyzing established trends, Monopar Therapeutics Inc. looks set to move in May 2026. Projections place the stock between $53.06 and $69.01, averaging around $60.99. This suggests a +9.65% gain from current levels.
June 2026
Market indicators suggest Monopar Therapeutics Inc. could experience notable changes during June 2026. Prices could fluctuate within $50.53 to $67.61, with a midpoint forecast of $59.36. The stock might deliver a +6.72% gain.
July 2026
Forecasting for July 2026, models estimate that Monopar Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $53.29 and $74.42, averaging $63.12. This signals a positive trajectory with potential returns around +13.48%.
August 2026
According to our latest forecast models, Monopar Therapeutics Inc. (MNPR) is positioned to show a strong performance in August 2026. The price is predicted to move between $57.75 and $74.91, settling at an average of $66.61. This could translate to a +19.76% gain.
September 2026
Based on current market signals, Monopar Therapeutics Inc. is projected to trend september 2026. We forecast a trading range from $60.52 to $77.24, with a likely average price of $68.95. Investors could expect a potential return of +23.97%.
October 2026
Our predictive algorithms indicate Monopar Therapeutics Inc. stock may see a shift in October 2026. The expected range spans $59.33–$85.92, with an average target of $69.75. This represents a positive outlook and a possible gain of +25.40%.
November 2026
Analyzing established trends, Monopar Therapeutics Inc. looks set to move in November 2026. Projections place the stock between $59.31 and $87.14, averaging around $69.05. This suggests a +24.15% gain from current levels.
December 2026
Market indicators suggest Monopar Therapeutics Inc. could experience notable changes during December 2026. Prices could fluctuate within $62.53 to $82.69, with a midpoint forecast of $72.59. The stock might deliver a +30.51% gain.
January 2027
Forecasting for January 2027, models estimate that Monopar Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $66.94 and $83.71, averaging $75.51. This signals a positive trajectory with potential returns around +35.76%.
February 2027
According to our latest forecast models, Monopar Therapeutics Inc. (MNPR) is positioned to show a strong performance in February 2027. The price is predicted to move between $69.36 and $86.16, settling at an average of $77.77. This could translate to a +39.82% gain.
MNPR's history of dividends and stock splits also plays a role in long-term investor confidence.

